In an interview with The Wall Street Journal that was published on Monday, Shkreli, who resigned as Turing CEO last week after his arrest, floated his own theory.
Advertisement
US crude briefly rises to premium over Brent
Analysts warned oil could be vulnerable ahead of a weekly petroleum inventory release on Wednesday by the US Department of Energy. Oil prices rose slightly today with Brent prices bouncing back from 11-year lows caused largely by a global oversupply of crude.
He’s been dubbed the internet’s most hated man and is now facing fraud charges, so we reckon it was just a matter of time before this happened.
Peterson lone Viking named to Pro Bowl
Center Joe Berger has played well since replacing injured John Sullivan at center, but he wasn’t named to the team. Baldwin’s 10 TD grabs in four games matches Jerry Rice’s record for the most TD catches over a four-game span.
Shkreli was arrested for engaging in what USA prosecutors said was a Ponzi-like scheme at his former hedge fund and a pharmaceutical company he previously headed.
Star Wars: The Force Awakens Breaks Box Office Records
Fandango reports this morning that it sold 37% of the estimated 8.5M-0M opening weekend ticket sales for the J.J. According to CNN, the film brought in 8 million internationally.
Following his arrest, Shkreli resigned from his role at Turing and was released on $5 million bail – the terms of which mean he can not leave the state of NY.
CEO is a title Martin Shkreli can no longer list on his business cards.
Last week, Shkreli was removed as chief executive of Turing Pharmaceuticals, a privately held company in NY that he co-founded late a year ago.
KaloBios said Monday that it terminated Shkreli last Thursday, but it did not give a reason.
Shkreli became the chief executive of KaloBios in November after obtaining 70 percent of its outstanding shares. Turing was at the center of the controversy that led to Shkreli’s nationwide infamy as the company purchased the rights to Daraprim and then promptly spiked its price by 5,000%.
While making the announcement in a statement, the company did not say whether it was looking for an interim CEO or permanent CEO to replace Shkreli.
His arrest was not related to the dramatic price hike for Daraprim. “Willing to donate hundreds of thousands to charities before I go to prison…” and numerous unprintable ones accumulated on the page before he regained control and deleted them. Now, the former CEO has also lost control of his Twitter account to a hacker who has posted a series over the past 11 hours, at the time of publishing.
Chase joined KaloBios’ board of directors when Shkreli took over the company along with a larger investor group including Marek Biestek and David Moradi. Trading in the stock has been halted since Thursday. The company has struggled to develop drugs that treat cancer and leukemia. The SEC complaint accuses Shkreli of a string of abuses, including exaggerating to hedge-fund investors his investment performance and assets under management.
Advertisement
“I am confident I will prevail”, Shkreli wrote on Twitter on Saturday.
